person with thalassemia

CAF Launches Three New Patient Services Programs

July 16, 2018 – The Cooley’s Anemia Foundation is proud to announce three new programs intended to benefit members of the U.S. thalassemia community. These programs are: Support for Significant Travel to Treatment Centers The Cooley’s Anemia Foundation (CAF) is offering limited financial assistance to individuals with thalassemia who live 150 or more miles from […]

Read more


CDC Features Patient Profile in Honor of International Thalassemia Day

May 8, 2018 – In honor of International Thalassemia Day (May 8), the Centers for Disease Control and Prevention (CDC) has posted information about thalassemia on their website and a new profile of CAF Board Member Maria Hadjidemetriou on their website. You can view this page by clicking here . CAF thanks the CDC for their support […]

Read more


Children’s Healthcare of Atlanta Taking Appointments During Week of CAF Patient-Family Conference

April 16, 2018 – If you plan to attend the CAF Patient-Family Conference in Atlanta this July 6-8 and would like to undergo a Comprehensive Care Evaluation at the nearby Children’s Healthcare of Atlanta (CHOA) Thalassemia Treatment Center, please call to schedule an appointment: Returning Patients: 404-785-3522 New Patients: 404-785-3519 Note: Both pediatric and adult […]

Read more


Registration Now Open for 2018 Patient-Family Conference

March 26, 2018 – Registration is now open for CAF’s 2018 Patient-Family Conference!  This year’s Conference will be held from July 6-8 at the Westin Atlanta Airport Hotel in Atlanta, GA.  The 2018 Patient-Family Conference is a unique opportunity for U.S. individuals with thalassemia and their family members (parents, siblings, spouses, etc.)  to meet other […]

Read more


Phase 2 Study of LJPC-401 for the Treatment of Myocardial Iron Overload in Adults with Transfusion-Dependent Beta Thalassemia Has Now Begun

January 11, 2018 – La Jolla Pharmaceutical Company has initiated a Phase 2 study to evaluate the effect of LJPC-401 (synthetic human hepcidin) on myocardial iron overload in adult patients with transfusion-dependent beta thalassemia. Hepcidin is a hormone that regulates iron absorption and distribution in the body. Hepcidin prevents excessive iron accumulation in vital organs such […]

Read more


Slides from 2017 Patient-Family Conference

August 4, 2017 – CAF is pleased to make available slides from many of the presentations from the 2017 Patient-Family Conference held July 7-9, 2017 in Hyattsville MD. PDFs of the presentations may be accessed by clicking on the links below. Please mark your calendars for July 6-8, 2018, the dates for the 2018 Patient-Family […]

Read more


CAF Announces Dates for 2018 Patient-Family Conference in Atlanta, GA

August 1, 2017 – CAF is happy to announce the dates for our 2018 Patient-Family Conference, to be held in Atlanta, Georgia from July 6-8. We will share additional details as they become available. We hope you will be able to join us next year! Update: Register now at www.docbw.com/meet/caf/.

Read more


Photo Gallery for 2017 Patient-Family Conference

July 19, 2017- The 2017 CAF Patient-Family Conference was a true success, with a record-breaking attendance of over 300 members of the U.S. thalassemia community. This annual Conference provides up-to-date information on thalassemia treatment, and gives members of the thalassemia community an opportunity to get to know each other and share experiences. Browse the gallery […]

Read more


CAF Accepting Applications for 2016-2017 Patient Incentive Awards

May 4, 2017 – The Cooley’s Anemia Foundation is accepting applications for its 2016-2017 Patient Incentive Awards. These awards are open to U.S. thalassemia patients who are currently pursuing education in a graduate, undergraduate, associate, certificate or vocational level. The purpose of these Awards is to inspire patients to further their education and career goals and […]

Read more


College Age Thalassemia Students – Learn About Libra Group Internships

April 19, 2017 – CAF Board member Maria Hadjidemetriou has been in touch with the Libra Group, a prestigious international business group, about their exciting internship program. Thalassemia patients who are currently enrolled in an undergraduate degree program and who are interested in an internship may wish to look into this program.  Full details about […]

Read more


Secured By miniOrange